Thermo Fisher Scientific | Beneficio Operativo



Operating Profit Cambio Fecha
Abbott USD 1.91B 41M 2024-12
Agilent USD 376M 32M 2025-01
Becton, Dickinson and Co. USD 453M 195M 2024-12
Bio Techne USD 47.42M 7.43M 2024-12
Bio-Rad Laboratories USD 58.4M 6.07M 2024-12
Boston Scientific USD 675M 58M 2024-12
Bruker USD 64.1M 4M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Danaher USD 1.42B 467M 2024-12
Dentsply International USD -509000000 47M 2024-12
Edwards Lifesciences USD 312.6M 38M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
General Electric USD 2.09B 292M 2024-12
Henry Schein USD 155M 2M 2024-12
Hologic USD 229.8M 200K 2024-12
Illumina USD 175M 566M 2024-12
Intuitive Surgical USD 734.9M 157.6M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
Laboratory Of America USD 216.5M 37.6M 2024-12
Medtronic USD 1.65B 51M 2025-01
Mettler Toledo International USD 314.55M 295.95M 2024-12
Myriad Genetics USD -39000000 19M 2024-12
Olympus JPY 38.26B 4.79B 2024-12
Patterson Companies USD 45.44M 7.8M 2025-01
Quest Diagnostics USD 361M 8M 2024-12
Repligen USD -7830000 10.29M 2024-09
Revvity USD 118.75M 20.6M 2024-12
Stryker USD 581M 504M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Veracyte USD 4.18M 7.84M 2024-12
Waters USD 292.26M 81.13M 2024-12
Zimmer Biomet Holdings USD 389M 109.5M 2024-12



Thermo Fisher Scientific Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.